APA (7th ed.) Citation

Vernon, A., Burman, W., Benator, D., Khan, A., Bozeman, L., Vernon, A., . . . Bozeman, L. (1999). Acquired rifamycin monoresistance in patients with HIV-related tuberculosis treated with once-weekly rifapentine and isoniazid. Tuberculosis Trials Consortium. Lancet, 353(9167), 1843. https://doi.org/10.1016/S0140-6736(98)11467-8

Chicago Style (17th ed.) Citation

Vernon, Andrew, et al. "Acquired Rifamycin Monoresistance in Patients with HIV-related Tuberculosis Treated with Once-weekly Rifapentine and Isoniazid. Tuberculosis Trials Consortium." Lancet 353, no. 9167 (1999): 1843. https://doi.org/10.1016/S0140-6736(98)11467-8.

MLA (9th ed.) Citation

Vernon, Andrew, et al. "Acquired Rifamycin Monoresistance in Patients with HIV-related Tuberculosis Treated with Once-weekly Rifapentine and Isoniazid. Tuberculosis Trials Consortium." Lancet, vol. 353, no. 9167, 1999, p. 1843, https://doi.org/10.1016/S0140-6736(98)11467-8.